These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
37 related articles for article (PubMed ID: 20223350)
1. [Anti-apoptotic mechanisms in small-cell lung carcinoma]. Loriot Y; Calderaro J; Soria JC; Deutsch E; Vielh P Ann Pathol; 2010 Feb; 30(1):17-24. PubMed ID: 20223350 [TBL] [Abstract][Full Text] [Related]
2. The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression. Roz L; Andriani F; Ferreira CG; Giaccone G; Sozzi G Oncogene; 2004 Dec; 23(56):9102-10. PubMed ID: 15489891 [TBL] [Abstract][Full Text] [Related]
3. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells. Ikuta K; Takemura K; Kihara M; Naito S; Lee E; Shimizu E; Yamauchi A Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947 [TBL] [Abstract][Full Text] [Related]
4. Endogenously released Smac is insufficient to mediate cell death of human lung carcinoma in response to etoposide. Bartling B; Lewensohn R; Zhivotovsky B Exp Cell Res; 2004 Aug; 298(1):83-95. PubMed ID: 15242764 [TBL] [Abstract][Full Text] [Related]
5. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival. Volm M; Koomägi R Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513 [TBL] [Abstract][Full Text] [Related]
6. Cellular predictive factors for the drug response of lung cancer. Volm M; Rittgen W Anticancer Res; 2000; 20(5B):3449-58. PubMed ID: 11131647 [TBL] [Abstract][Full Text] [Related]
7. Activation of corticotropin-releasing factor receptor 2 inhibits the growth of human small cell lung carcinoma cells. Wang J; Jin L; Chen J; Li S Cancer Invest; 2010 Feb; 28(2):146-55. PubMed ID: 19968503 [TBL] [Abstract][Full Text] [Related]
8. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells. Sun SY; Yue P; Zhou JY; Wang Y; Choi Kim HR; Lotan R; Wu GS Biochem Biophys Res Commun; 2001 Jan; 280(3):788-97. PubMed ID: 11162590 [TBL] [Abstract][Full Text] [Related]
10. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. Yang L; Mashima T; Sato S; Mochizuki M; Sakamoto H; Yamori T; Oh-Hara T; Tsuruo T Cancer Res; 2003 Feb; 63(4):831-7. PubMed ID: 12591734 [TBL] [Abstract][Full Text] [Related]
11. Calmodulin inhibition contributes to sensitize TRAIL-induced apoptosis in human lung cancer H1299 cells. Hwang MK; Min YK; Kim SH Biochem Cell Biol; 2009 Dec; 87(6):919-26. PubMed ID: 19935877 [TBL] [Abstract][Full Text] [Related]
12. Melanoma antigen A4 is expressed in non-small cell lung cancers and promotes apoptosis. Peikert T; Specks U; Farver C; Erzurum SC; Comhair SA Cancer Res; 2006 May; 66(9):4693-700. PubMed ID: 16651421 [TBL] [Abstract][Full Text] [Related]
13. Combinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cells. Hajji N; Wallenborg K; Vlachos P; Nyman U; Hermanson O; Joseph B Oncogene; 2008 May; 27(22):3134-44. PubMed ID: 18071312 [TBL] [Abstract][Full Text] [Related]
14. RasGTPase-activating protein is a target of caspases in spontaneous apoptosis of lung carcinoma cells and in response to etoposide. Bartling B; Yang JY; Michod D; Widmann C; Lewensohn R; Zhivotovsky B Carcinogenesis; 2004 Jun; 25(6):909-21. PubMed ID: 14742324 [TBL] [Abstract][Full Text] [Related]
15. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Mueller T; Voigt W; Simon H; Fruehauf A; Bulankin A; Grothey A; Schmoll HJ Cancer Res; 2003 Jan; 63(2):513-21. PubMed ID: 12543810 [TBL] [Abstract][Full Text] [Related]
16. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells. Lahiry L; Saha B; Chakraborty J; Adhikary A; Mohanty S; Hossain DM; Banerjee S; Das K; Sa G; Das T Carcinogenesis; 2010 Feb; 31(2):259-68. PubMed ID: 19969555 [TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637 [TBL] [Abstract][Full Text] [Related]
18. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2. Poulaki V; Mitsiades N; Romero ME; Tsokos M Cancer Res; 2001 Jun; 61(12):4864-72. PubMed ID: 11406564 [TBL] [Abstract][Full Text] [Related]
19. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes. Moriyama H; Yonehara S Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920 [TBL] [Abstract][Full Text] [Related]